Kimberly A Waller1, Ling X Zhang, Braden C Fleming, Gregory D Jay. 1. Department of Orthopedics, and Department of Emergency Medicine, Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence, Rhode Island 02903, USA.
Abstract
OBJECTIVE: Symptomatic osteoarthritis (OA) is a common painful disease with limited treatment options. A rising number of patients with OA have been treated with intraarticular injections of hyaluronic acid, including the high-molecular-weight hylan G-F 20, which is injected following arthrocentesis. We investigated the effectiveness of hylan G-F 20 to lower coefficient of friction (COF) and prevent chondrocyte apoptosis in vitro. METHODS: A disc-on-disc bovine cartilage bearing was used to measure the static and kinetic COF when lubricated with hylan G-F 20, human synovial fluid (HSF), and phosphate buffered saline (PBS). Following friction testing, we stained paraffin-embedded sections of these cartilage bearings for activated caspase-3, a marker of apoptosis. RESULTS: Bearings lubricated with hylan G-F 20 had kinetic COF values that were similar to bearings lubricated with PBS, but significantly higher than those lubricated with HSF. There were no significant differences in static COF values in bearings lubricated with hylan G-F 20 as compared to PBS or HSF. However, bearings lubricated with HSF had significantly lower static COF values compared to bearings lubricated with PBS. The mean percentage of caspase-3-positive chondrocytes in the superficial and upper intermediate zones of bearings lubricated with hylan G-F 20 was significantly higher compared to that of bearings lubricated with HSF or unloaded controls, but significantly lower than in those lubricated with PBS. CONCLUSION: These findings indicate that joint lubrication may prevent chondrocyte apoptosis by lowering the COF. Further, removal of synovial fluid prior to hylan G-F 20 injection may be detrimental to cartilage health.
OBJECTIVE: Symptomatic osteoarthritis (OA) is a common painful disease with limited treatment options. A rising number of patients with OA have been treated with intraarticular injections of hyaluronic acid, including the high-molecular-weight hylanG-F 20, which is injected following arthrocentesis. We investigated the effectiveness of hylanG-F 20 to lower coefficient of friction (COF) and prevent chondrocyte apoptosis in vitro. METHODS: A disc-on-disc bovinecartilage bearing was used to measure the static and kinetic COF when lubricated with hylanG-F 20, human synovial fluid (HSF), and phosphate buffered saline (PBS). Following friction testing, we stained paraffin-embedded sections of these cartilage bearings for activated caspase-3, a marker of apoptosis. RESULTS: Bearings lubricated with hylanG-F 20 had kinetic COF values that were similar to bearings lubricated with PBS, but significantly higher than those lubricated with HSF. There were no significant differences in static COF values in bearings lubricated with hylanG-F 20 as compared to PBS or HSF. However, bearings lubricated with HSF had significantly lower static COF values compared to bearings lubricated with PBS. The mean percentage of caspase-3-positive chondrocytes in the superficial and upper intermediate zones of bearings lubricated with hylanG-F 20 was significantly higher compared to that of bearings lubricated with HSF or unloaded controls, but significantly lower than in those lubricated with PBS. CONCLUSION: These findings indicate that joint lubrication may prevent chondrocyte apoptosis by lowering the COF. Further, removal of synovial fluid prior to hylanG-F 20 injection may be detrimental to cartilage health.
Authors: J Marcelino; J D Carpten; W M Suwairi; O M Gutierrez; S Schwartz; C Robbins; R Sood; I Makalowska; A Baxevanis; B Johnstone; R M Laxer; L Zemel; C A Kim; J K Herd; J Ihle; C Williams; M Johnson; V Raman; L G Alonso; D Brunoni; A Gerstein; N Papadopoulos; S A Bahabri; J M Trent; M L Warman Journal: Nat Genet Date: 1999-11 Impact factor: 38.330
Authors: Erin Teeple; Khaled A Elsaid; Gregory D Jay; Ling Zhang; Gary J Badger; Matthew Akelman; Thomas F Bliss; Braden C Fleming Journal: Am J Sports Med Date: 2010-09-20 Impact factor: 6.202
Authors: M J López-Armada; B Caramés; M Lires-Deán; B Cillero-Pastor; C Ruiz-Romero; F Galdo; F J Blanco Journal: Osteoarthritis Cartilage Date: 2006-02-21 Impact factor: 6.576
Authors: Katherine M Larson; Ling Zhang; Khaled A Elsaid; Tannin A Schmidt; Braden C Fleming; Gary J Badger; Gregory D Jay Journal: J Orthop Res Date: 2017-03-02 Impact factor: 3.494
Authors: Eben G Estell; Lance A Murphy; Lianna R Gangi; Roshan P Shah; Gerard A Ateshian; Clark T Hung Journal: J Biomech Date: 2021-08-04 Impact factor: 2.789
Authors: Kimberly A Waller; Ling X Zhang; Khaled A Elsaid; Braden C Fleming; Matthew L Warman; Gregory D Jay Journal: Proc Natl Acad Sci U S A Date: 2013-03-25 Impact factor: 11.205
Authors: Adele Hill; Kimberly A Waller; Yajun Cui; Justin M Allen; Patrick Smits; Ling X Zhang; Ugur M Ayturk; Steven Hann; Samantha G Lessard; David Zurakowski; Matthew L Warman; Gregory D Jay Journal: Arthritis Rheumatol Date: 2015-11 Impact factor: 10.995
Authors: A Migliore; E Bizzi; O De Lucia; A Delle Sedie; M Bentivegna; Asmaa Mahmoud; C Foti Journal: Clin Med Insights Arthritis Musculoskelet Disord Date: 2016-05-25
Authors: Naga Padmini Karamchedu; Josef N Tofte; Kimberly A Waller; Ling X Zhang; Tarpit K Patel; Gregory D Jay Journal: Arthritis Res Ther Date: 2016-03-14 Impact factor: 5.156